Inventor
QIAO LIXIN
US45 patents
⚠️ This page may combine multiple inventors who share the name “QIAO LIXIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CAR LLC
12 patentsUS9987276B2Jun 5, 2018
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE CAR LLC23 citations94
US10010548B2Jul 3, 2018
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC15 citations92
US10596172B2Mar 24, 2020
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC5 citations84
US10138256B2Nov 27, 2018
MK2 inhibitors and uses thereof
CELGENE CAR LLC11 citations84
US9980964B2May 29, 2018
ERK inhibitors and uses thereof
CELGENE CAR LLC11 citations84
US9796700B2Oct 24, 2017
ERK inhibitors and uses thereof
CELGENE CAR LLC7 citations84
US11351168B1Jun 7, 2022
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE CAR LLC2 citations73
US10828300B2Nov 10, 2020
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE CAR LLC3 citations73
US11098061B2Aug 24, 2021
MK2 inhibitors and uses thereof
CELGENE CAR LLC0 citations62
US11542492B2Jan 3, 2023
Ligand-directed covalent modification of protein
CELGENE CAR LLC1 citations58
US9694086B2Jul 4, 2017
HCV protease inhibitors and uses thereof
CELGENE CAR LLC0 citations52
US9676785B2Jun 13, 2017
HCV protease inhibitors and uses thereof
CELGENE CAR LLC0 citations52
CELGENE AVILOMICS RES INC
11 patentsUS8609679B2Dec 17, 2013
2,4-diaminopyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC84 citations99
US9212181B2Dec 15, 2015
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC34 citations98
US9561228B2Feb 7, 2017
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC37 citations97
US8710222B2Apr 29, 2014
2,4-disubstituted pyrimidines useful as kinase inhibitors
CELGENE AVILOMICS RES INC52 citations97
US9409921B2Aug 9, 2016
2,4-disubstituted pyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC25 citations94
US9296737B2Mar 29, 2016
Substituted 2,4-diaminopyrimidines as kinase inhibitors
CELGENE AVILOMICS RES INC27 citations94
US9145387B2Sep 29, 2015
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC21 citations92
US9504686B2Nov 29, 2016
ERK inhibitors and uses thereof
CELGENE AVILOMICS RES INC10 citations84
US8980935B2Mar 17, 2015
HCV protease inhibitors and uses thereof
CELGENE AVILOMICS RES INC7 citations84
US9422333B2Aug 23, 2016
HCV protease inhibitors and uses thereof
CELGENE AVILOMICS RES INC2 citations63
US10662195B2May 26, 2020
Protein kinase conjugates and inhibitors
CELGENE AVILOMICS RES INC1 citations61
NIU DEQIANG
5 patentsUS8778877B2Jul 15, 2014
HCV protease inhibitors and uses thereof
NIU DEQIANG10 citations84
US8741837B2Jun 3, 2014
HCV protease inhibitors and uses thereof
NIU DEQIANG10 citations84
US8524760B2Sep 3, 2013
HCV protease inhibitors and uses thereof
NIU DEQIANG9 citations84
US8293705B2Oct 23, 2012
HCV protease inhibitors and uses thereof
NIU DEQIANG12 citations84
US8188137B2May 29, 2012
HCV protease inhibitors and uses thereof
NIU DEQIANG13 citations84
SINGH JUSWINDER
3 patentsUS8450335B2May 28, 2013
2,4-disubstituted pyrimidines useful as kinase inhibitors
SINGH JUSWINDER130 citations98
US8338439B2Dec 25, 2012
2,4-disubstituted pyrimidines useful as kinase inhibitors
SINGH JUSWINDER175 citations98
US9556426B2Jan 31, 2017
Protein kinase conjugates and inhibitors
SINGH JUSWINDER3 citations71
MASSACHUSETTS EYE & EAR INFIRMARY
3 patentsUS10406163B2Sep 10, 2019
Compounds that enhance Atoh1 expression
MASSACHUSETTS EYE & EAR INFIRMARY6 citations83
US11160808B2Nov 2, 2021
Compounds that enhance Atoh1 expression
MASSACHUSETTS EYE & EAR INFIRMARY0 citations62
US9433610B2Sep 6, 2016
Compounds that enhance Atoh1 expression
MASSACHUSETTS EYE & EAR INFIRMARY0 citations51